
News|Podcasts|June 27, 2025
Allen's Story: The Promising Potential of Intratumoral Immunotherapy
Advertisement
Allen Rappert, a St. Louis resident diagnosed with stage four squamous cell carcinoma, found hope through Dr. Jason Williams' intratumoral immunotherapy at the Williams Cancer Institute. Despite a grim prognosis, Allen's tumor was targeted directly, leading to his cancer-free status. Dr. Williams helped develop this treatment approach, which involves injecting immunotherapy drugs directly into tumors. Allen's case highlights the effectiveness of this method, which has a high success rate. Dr. Williams emphasizes the need for early treatment and shares his vision for future cancer care, advocating for immediate treatment at the time of biopsy.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
4
What Pharmacists Should Know About the Ifosfamide Shortage
5





































































































